Charlotte D. Jacobs

Oncology

875 Blake Wilbur Dr # 2241
Palo Alto, CA 94304

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Journal: Cancer

Published: March 09, 2017

Phase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report.

Phase I and pharmacokinetic study of bexarotene in combination with gefitinib in the third-line treatment of non-small-cell lung cancer: brief report.

Journal: Anti-cancer drugs

Published: April 05, 2013

Impact of a program to diminish gender insensitivity and sexual harassment at a medical school.

Impact of a program to diminish gender insensitivity and sexual harassment at a medical school.

Journal: Academic medicine : journal of the Association of American Medical Colleges

Published: May 29, 2000

Showing 1-3 of 3

Last Updated: 09/26/2026